[1例晚期胃癌伴骨转移及弥散性血管内凝血对口服替吉奥有反应的病例]
[A case of advanced gastric cancer with bone metastases and DIC responding to oral administration of TS-1].
作者信息
Omatsu Tatsushi, Ichikawa Hiroshi, Kawahito Yutaka, Ashihara Eiji, Yamamoto Aihiro, Kadoya Masatoshi, Takegami Toru, Takanashi Yoshiaki, Naito Yuji, Yoshida Norimasa, Sugino Shigeru, Yoshikawa Toshikazu
机构信息
First Dept. of Internal Medicine, Kyoto Prefectural University of Medicine.
出版信息
Gan To Kagaku Ryoho. 2003 Jun;30(6):869-73.
The patient was a 71-year-old man whose chief complaints were staggering and fatigue. As a result of various examinations, he was diagnosed with advanced gastric cancer, Borrmann 3, with disseminated intravascular coagulation (DIC) and bone metastases. The DIC was treated with oral administration of TS-1 (120 mg/day). Furthermore, both the primary gastric tumor and metastatic bone lesions were reduced in size by the treatment with TS-1. TS-1 appears to be an effective therapeutic agent for advanced gastric cancer with DIC or bone metastases.
该患者为71岁男性，主要症状为蹒跚步态和疲劳。经过各项检查，他被诊断为晚期胃癌，Borrmann 3型，伴有弥散性血管内凝血（DIC）和骨转移。采用口服替吉奥胶囊（TS-1，120毫克/天）治疗DIC。此外，通过替吉奥胶囊治疗，原发性胃肿瘤和骨转移病灶的大小均有所缩小。替吉奥胶囊似乎是治疗伴有DIC或骨转移的晚期胃癌的有效治疗药物。
Zotero 插件